SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-016202
Filing Date
2024-01-26
Accepted
2024-01-26 09:00:32
Documents
13
Period of Report
2024-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d750775d8k.htm   iXBRL 8-K 53292
2 EX-10.1 d750775dex101.htm EX-10.1 21522
  Complete submission text file 0001193125-24-016202.txt   201319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20240125.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20240125_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20240125_pre.xml EX-101.PRE 10806
7 EXTRACTED XBRL INSTANCE DOCUMENT d750775d8k_htm.xml XML 3216
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 24564372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)